intrahepatic cholangiocarcinoma
Showing 1 - 25 of 84
Intrahepatic Cholangiocarcinoma Trial (procedure, drug, biological)
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Biopsy
- +7 more
- (no location specified)
Sep 21, 2023
Intrahepatic Cholangiocarcinoma Trial in Shanghai (HMPL-453, Rabeprazole)
Active, not recruiting
- Intrahepatic Cholangiocarcinoma
-
Shanghai, Shanghai, ChinaShanghai Xuhui Central Hospital
Jun 24, 2023
Carcinoma, Intrahepatic Cholangiocarcinoma, Digestive System Tumors Trial in Guangzhou (Pemigatinib, PD-1 Inhibitors)
Recruiting
- Carcinoma
- +4 more
- Pemigatinib
- PD-1 Inhibitors
-
Guangzhou, Guangdong, ChinaLei Zhang
Jun 21, 2023
Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)
Not yet recruiting
- Biliary Tract Diseases
- +5 more
- no interventions
- (no location specified)
Jun 1, 2023
Intrahepatic Cholangiocarcinoma Trial in Shanghai (Cadonilimab+Gem/Cis)
Active, not recruiting
- Intrahepatic Cholangiocarcinoma
-
Shanghai, Shanghai, ChinaEastern hepatobilliary surgery hospital
Mar 22, 2023
Multi-Platform Profiling of Resected Biliary Tract Cancer
Recruiting
- Biliary Tract Cancer
- +7 more
- Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
-
Chicago, Illinois
- +1 more
Jan 23, 2023
Therapeutic Assistance and Decision-making Algorithms in
Not yet recruiting
- Hepatocellular Carcinoma
- +5 more
- ADBoard
-
Berlin, GermanySurgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
Jan 12, 2023
Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Common Bile Duct Tumors Trial in Rotterdam (Endoscopic Ultrasound
Recruiting
- Hilar Cholangiocarcinoma
- +4 more
- Endoscopic Ultrasound registration
-
Rotterdam, Zuid-Holland, NetherlandsErasmus University Medical Center
Jan 11, 2023
Durvalumab, Intrahepatic Cholangiocarcinoma, Gemcis Trial in Tianjin (Durvalumab, Surgery, Gemcitabine)
Recruiting
- Durvalumab
- +2 more
- Durvalumab
- +3 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Jan 3, 2023
Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,
Suspended
- Distal Bile Duct Adenocarcinoma
- +7 more
- Cisplatin
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Predict Efficacy of GC in Treatment of Intrahepatic
Not yet recruiting
- Organoids
- Intrahepatic Cholangiocarcinoma
- gemcitabine + cisplatin
- (no location specified)
Nov 30, 2022
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases Trial in Belgium, United Kingdom (MIV-818
Recruiting
- Hepatocellular Carcinoma
- +2 more
- MIV-818 (fostroxacitabine bralpamide) + pembrolizumab
- MIV-818 (fostroxacitabine bralpamide) + lenvatinib
-
Antwerp, Belgium
- +16 more
Nov 11, 2022
Intrahepatic Cholangiocarcinoma Trial in China, United States (Extend LymphAdenectomy)
Recruiting
- Intrahepatic Cholangiocarcinoma
- Extend LymphAdenectomy
-
Baltimore, Maryland
- +12 more
Nov 7, 2022
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Houston (SD-101, Pembrolizumab, Nivolumab)
Recruiting
- Hepatocellular Carcinoma
- Intrahepatic Cholangiocarcinoma
- SD-101
- +3 more
-
New York, New York
- +3 more
Oct 19, 2022
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Frankfurt, Hannover, Jena (Delcath Hepatic Delivery System,
Terminated
- Hepatocellular Carcinoma
- Intrahepatic Cholangiocarcinoma
- Delcath Hepatic Delivery System
- Melphalan
-
Frankfurt, Germany
- +2 more
Oct 13, 2022
Intrahepatic Cholangiocarcinoma Trial in Oslo (Liver Transplant)
Recruiting
- Intrahepatic Cholangiocarcinoma
- Liver Transplant
-
Oslo, NorwayOslo University Hospital
Oct 4, 2022
Intrahepatic Cholangiocarcinoma Trial in Hangzhou (Tislelizumab combined with GEMOX (GOT) regimen)
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Tislelizumab combined with GEMOX (GOT) regimen
-
Hangzhou, Zhejiang, China1# Banshan East Rd. Zhejiang cancer hospital
Sep 24, 2022
Intrahepatic Cholangiocarcinoma Trial in Tianjin (Regorafenib and HAIC, FOLFOX)
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Regorafenib and HAIC
- FOLFOX
-
Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Sep 7, 2022
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Intrahepatic Cholangiocarcinoma Trial in Shanghai (Toripalimab, Lenvatinib mesylate capsules, Placebo IV)
Not yet recruiting
- Intrahepatic Cholangiocarcinoma
- Toripalimab
- +6 more
-
Shanghai, Shanghai, ChinaZhongshan Hospital affiliated to Fudan University
Aug 12, 2022
/or PD-1 Inhibitors for Unresectable Intrahepatic
Completed
- Intrahepatic Cholangiocarcinoma
- hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, fluorouracil, and leucovorin (FOLFOX)
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 7, 2022